ALZHEIMER'S DISEASE COOPERATIVE STUDY

阿尔茨海默病合作研究

• 批准号: 6117126
• 负责人: Bruce Lee Miller
• 金额: $ 3.89万
• 依托单位: LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 1998
• 资助国家: 美国
• 起止时间: 1998-12-01 至 1999-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6117126
• 关键词: Alzheimer's disease; brain disorder chemotherapy; clinical research; cooperative study; drug screening /evaluation; human subject; human therapy evaluation; mental disorder chemotherapy; mental health; outcomes research; pathologic process; physical fitness; prednisone

To study the health status and thinking skills of patients with Alzheimer's disease. Also the tests that will be done are being assessed for their possible value in assessing patients with mental impairment. To see if prednisone, a corticosteroid, slows the rate of progression of Alzheimer's disease.

研究患有此病的患者的健康状况和思维能力 阿尔茨海默病。还将评估将要进行的测试 其在评估精神障碍患者方面可能具有的价值。 观察泼尼松（一种皮质类固醇）是否可以减缓病情进展速度 阿尔茨海默病。